Journal article
Characterizing Cannabidiol Use in a Breast Cancer Population
Clinical breast cancer, Vol.25(5), pp.464-471.e3
07/2025
DOI: 10.1016/j.clbc.2025.02.003
PMID: 40021432
Abstract
Cannabidiol (CBD) is a phytocannabinoid found in the plant Cannabis sativa and is thought to have broad potential therapeutic value. Little is reported on CBD use in patients with breast cancer (BC). This survey study aimed to characterize CBD use patterns and reported benefits among patients with BC, while also identifying barriers and limitations to its use.
Individuals seen at the University of Michigan Rogel Cancer Center for a diagnosis of BC accessed the anonymous online survey characterizing current and former CBD use via flyer posted in clinic. Survey questions were adapted from a previously published questionnaire conducted in patients with chronic pain conditions. The survey was accessed between September 2020 and February 2024.
Of 141 evaluable surveys, 68 patients (48.2%) reported prior or current CBD use. The most common reasons for current CBD use were management of pain (75.6%), anxiety (61.0%), and insomnia (58.5%). The biggest median self-reported improvement with use of CBD was in insomnia followed by pain. Patients mainly stopped using CBD because it was ineffective (46.2%), although some stopped due to negative side effects (7.7%).
Almost half of patients in this survey study reported previous or current CBD use, with improvements in symptoms. As CBD use increases in the clinical setting, it is important for physicians to help navigate concerns related to its use. Additional research is needed to determine which patient-reported symptoms are most likely to be impacted by CBD.
Though there is increasing use of cannabis products among patients with cancer, little has been reported specifically on cannabidiol (CBD) use in patients with breast cancer. This single institution survey study included 141 patients with breast cancer, 68 of whom reported prior or current CBD use. Patients who took CBD self-reported improvement in pain and insomnia, although additional research is needed to determine the true benefit in this population.
Details
- Title: Subtitle
- Characterizing Cannabidiol Use in a Breast Cancer Population
- Creators
- Nicole M. Grogan Fleege - University of Michigan Medical SchoolBradley T. Loeffler - University of Iowa Holden Comprehensive Cancer CenterKevin Boehnke - University of Michigan Medical SchoolN. Lynn Henry - University of Michigan Medical School
- Resource Type
- Journal article
- Publication Details
- Clinical breast cancer, Vol.25(5), pp.464-471.e3
- DOI
- 10.1016/j.clbc.2025.02.003
- PMID
- 40021432
- NLM abbreviation
- Clin Breast Cancer
- ISSN
- 1526-8209
- eISSN
- 1938-0666
- Publisher
- Elsevier Inc
- Grant note
- Conquer CancerASCO FoundationRising Tide Foundation
Thank you to the patients at the University of Michigan Rogel Cancer Center who took the time to participate in this survey study. This research was supported by grant funding from Conquer Cancer, the ASCO Foundation and the Rising Tide Foundation for Clinical Cancer Research .
- Language
- English
- Electronic publication date
- 02/2025
- Date published
- 07/2025
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984791078202771
Metrics
6 Record Views